BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6282469)

  • 21. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
    Anwar AR; Smithers SR; Kay AB
    J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
    [No Abstract]   [Full Text] [Related]  

  • 22. Schistosoma mansoni: complement-mediated cytotoxic activity in vitro and effect of decomplementation on acquired immunity in mice.
    Tavares CA; Gazzinelli G; Mota-Santos TA; Dias Da Silva W
    Exp Parasitol; 1978 Dec; 46(2):145-51. PubMed ID: 729694
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune mechanisms that stimulate mouse leukocyte migration in response to schistosomula of Schistosoma mansoni.
    James SL; Sher A
    J Immunol; 1980 Apr; 124(4):1837-44. PubMed ID: 6767775
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytolytic T lymphocytes recognize alloantigens on schistosomula of Schistosoma mansoni, but fail to induce damage.
    Butterworth AE; Vadas MA; Martz E; Sher A
    J Immunol; 1979 Apr; 122(4):1314-21. PubMed ID: 312837
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrastructural analysis of the cellular response to Schistosoma mansoni. III. The in vitro granuloma.
    Bentley AG; Doughty BL; Phillips SM
    Am J Trop Med Hyg; 1982 Nov; 31(6):1168-80. PubMed ID: 6890773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
    James SL; Correa-Oliveira R; Leonard EJ
    J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific triggering of macrophage accumulation at the site of secondary tumor challenge in mice with concomitant tumor immunity.
    Hopper KE; Nelson DS
    Cell Immunol; 1979 Sep; 47(1):163-9. PubMed ID: 509531
    [No Abstract]   [Full Text] [Related]  

  • 28. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.
    James SL
    J Immunol; 1986 May; 136(10):3872-7. PubMed ID: 3084646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages.
    Bout DT; Joseph M; David JR; Capron AR
    J Immunol; 1981 Jul; 127(1):1-5. PubMed ID: 7240738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of action of mouse macrophages as antitumor effector cells: role of arginase.
    Farram E; Nelson DS
    Cell Immunol; 1980 Oct; 55(2):283-93. PubMed ID: 7428048
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic studies of human schistosomiasis. II. Interrelationship of serum and ascitic fluid histamine, IgE and total eosinophils in acute and chronic human schistosomiasis.
    El-Din AH; Peters SM; Attia WM; Liu WJ; Ali MK; Bellanti JA
    Ann Allergy; 1983 Mar; 50(3):190-4. PubMed ID: 6829985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of macrophage activation and resistance by suppressor T lymphocytes in chronic murine Schistosoma mansoni infection.
    Olds GR; Ellner JJ
    J Immunol; 1984 Nov; 133(5):2720-4. PubMed ID: 6237154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splenic suppressor cells and cell-mediated cytotoxicity in murine schistosomiasis.
    Coulis PA; Lewert RM; Fitch FW
    J Immunol; 1978 Mar; 120(3):1074-6. PubMed ID: 147295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine eosinophilopoiesis: dose-dependent response to soluble antigens of Schistosoma mansoni.
    McGarry MP
    Exp Hematol; 1983 Feb; 11(2):139-46. PubMed ID: 6832242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Delayed hypersensitivity during experimental schistosomiasis with Schistosoma mansoni. 1. In vitro study in CBA mice].
    Vernes A; Floc'h F; Biguet J
    Ann Inst Pasteur (Paris); 1972 Nov; 123(5):707-20. PubMed ID: 4659554
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. IV. Analysis of the role of IgE antibodies and mast cells.
    Sher A; Correa-Oliveira R; Hieny S; Hussain R
    J Immunol; 1983 Sep; 131(3):1460-5. PubMed ID: 6193190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of regional lymph nodes after penetration of Schistosoma mansoni cercariae in naive and infected mice.
    Lozzi SP; Machado CR; Gerken SE; Mota-Santos TA
    Mem Inst Oswaldo Cruz; 1996; 91(4):491-8. PubMed ID: 9070409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The host antigen phenomenon in experimental murine schistosomiasis: the transfer of 3-week old Schistosoma mansoni between two inbred strains of mice.
    Boyer MH; Ketchum DG; Palmer PD
    Int J Parasitol; 1976 Jun; 6(3):235-8. PubMed ID: 776883
    [No Abstract]   [Full Text] [Related]  

  • 39. IgE receptors on phagocytic cells and immune response to schistosome infection.
    Capron M; Capron A; Joseph M; Verwaerde C
    Monogr Allergy; 1983; 18():33-44. PubMed ID: 6227818
    [No Abstract]   [Full Text] [Related]  

  • 40. Histopathological and ultrastructural studies of cutaneous reactions elicited in naive and chronically infected mice by invading schistosomula of Schistosoma mansoni.
    Incani RN; McLaren DJ
    Int J Parasitol; 1984 Jun; 14(3):259-76. PubMed ID: 6469446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.